Elyse Stock Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity

Elyse Stock is Chief Medical Officer of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 0 shares of BHVN, which is worth approximately $0. The most recent transaction as insider was on Oct 03, 2022, when has been sold 11,090 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $1,646,865. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Elyse Stock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 03 2022	SELL Sale (or disposition) back to the issuer	$1,646,865 $148.5 p/Share	11,090 Reduced 100.0%	0 Common Shares
Jan 07 2022	SELL Payment of exercise price or tax liability	$198,331 $128.87 p/Share	1,539 Reduced 12.19%	11,090 Common Shares
Jan 07 2022	BUY Exercise of conversion of derivative security	-	3,250 Added 20.47%	12,629 Common Shares
Jan 06 2022	SELL Payment of exercise price or tax liability	$227,655 $123.86 p/Share	1,838 Reduced 16.39%	9,379 Common Shares
Jan 06 2022	BUY Exercise of conversion of derivative security	-	3,750 Added 25.06%	11,217 Common Shares
Dec 15 2021	SELL Open market or private sale	$2,319,030 $105.8 p/Share	21,919 Reduced 74.59%	7,467 Common Shares
Dec 15 2021	BUY Exercise of conversion of derivative security	$346,539 $15.81 p/Share	21,919 Added 42.72%	29,386 Common Shares
Dec 14 2021	SELL Open market or private sale	$728,734 $105.02 p/Share	6,939 Reduced 48.17%	7,467 Common Shares
Dec 14 2021	BUY Exercise of conversion of derivative security	$109,706 $15.81 p/Share	6,939 Added 32.51%	14,406 Common Shares
Nov 25 2021	SELL Payment of exercise price or tax liability	$184,764 $115.55 p/Share	1,599 Reduced 17.64%	7,467 Common Shares
Nov 25 2021	BUY Exercise of conversion of derivative security	-	3,375 Added 27.13%	9,066 Common Shares
Jan 06 2021	SELL Payment of exercise price or tax liability	$145,665 $83.38 p/Share	1,747 Reduced 23.49%	5,691 Common Shares
Jan 06 2021	BUY Exercise of conversion of derivative security	-	3,750 Added 33.52%	7,438 Common Shares
Nov 25 2020	SELL Payment of exercise price or tax liability	$138,004 $90.14 p/Share	1,531 Reduced 29.34%	3,688 Common Shares
Nov 25 2020	BUY Exercise of conversion of derivative security	-	3,375 Added 39.27%	5,219 Common Shares

Elyse Stock

Chief Medical Officer

New Haven, CT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHVN shares.

Notify only if

Value

Insider Trading

Get notified when an Biohaven Pharmaceutical Holding CO Ltd. insider buys or sells BHVN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Biohaven Pharmaceutical Holding Co Ltd.

Track Activities on BHVN

Account